Abstract
Magnesium sulfate (MS) is standard of care for the prevention of moderate and severe cerebral palsy among women who are expected to deliver at less than 32 weeks of gestation. The recommended protocol is to stop MS after 12 hours if no sign of imminent delivery. Limited information exists as to whether longer courses of MS are associated with decreased risk for cerebral palsy and death in the children of women who deliver prior to 32 weeks of gestation. Our aim is to determine whether extended courses of MS in women at high risk for early preterm delivery are associated with decreased risk of cerebral palsy and death in their children.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call